HEAD NECK

Clinical trials for HEAD NECK explained in plain language.

Never miss a new study

Get alerted when new HEAD NECK trials appear

Sign up with your email to follow new studies for HEAD NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Cancer cocktail falls short: trial halted after only 4 patients

Disease control Terminated

This study tested whether adding the experimental drug magrolimab to a mix of approved cancer drugs (cetuximab plus either pembrolizumab or docetaxel) could shrink tumors or slow the growth of head and neck cancer that had come back or spread. Only 4 people took part before the t…

Matched conditions: HEAD NECK

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 22, 2026 13:52 UTC

HEAD NECK

Get alerted when new HEAD NECK trials appear

Cancer cocktail falls short: trial halted after only 4 patients